Efficacy and Safety of an Inactivated Whole-Virion SARS-CoV-2 Vaccine (CoronaVac) in Brazilian Healthcare Professionals: The PROFISCOV Trial
José Moreira, Elizabeth G. Patiño, Patricia Emilia Braga, Pedro Pacheco, Caroline Curimbaba, Christopher Gast, Ricardo Palácios, Mauro Teixeira, Fabiano Ramos, Gustavo Romero, Fabio Leal, Luiz Junior, Luiz Camargo, Francisco Aoki, Eduardo Coelho, André Siqueira, Sonia Raboni, Danise Oliveira, Paulo Tarso, Cor Fontes, Ana Lyrio, Mauricio Nogueira, Fernanda Boulos, Esper Kallas PROFISCOV study group
doi: https://doi.org/10.1101/2024.04.22.24306197
José Moreira
1Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil
Ph.D.Elizabeth G. Patiño
1Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil
Ph.D.Patricia Emilia Braga
1Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil
Ph.D.Pedro Pacheco
1Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil
STATCaroline Curimbaba
1Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil
MBAChristopher Gast
2PATH, Center for Innovation and Access, Seattle, WA, USA
Ph.D.Ricardo Palácios
3GSK, Siena, Italy
Ph.D.Mauro Teixeira
4Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil
Ph.D.Fabiano Ramos
5Hospital São Lucas da PUC, Porto Alegre, Brazil
Ph.D.Gustavo Romero
6Universidade de Brasileira, Brasília, Brazil
Ph.D.Fabio Leal
7Universidade de São Caetano do Sul, São Paulo, Brazil
Ph.D.Luiz Junior
8Instituto de Infectologia Emilio Ribas, São Paulo, Brazil
Ph.D.Luiz Camargo
9Hospital Albert Einstein, São Paulo, Brazil
Ph.D.Francisco Aoki
10Universidade de Campinas, Campinas, Brazil
Ph.D.Eduardo Coelho
11Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, Brazil
Ph.D.André Siqueira
12Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
Ph.D.Sonia Raboni
13Complexo Hospital das Clínicas da Universidade Federal do Paraná (EBSERH), Curitiba, Brazil
Ph.D.Danise Oliveira
14Centro de Pesquisa Clínica do Hospital Escola da Universidade Federal de Pelotas, Pelotas, Brazil
Ph.D.Paulo Tarso
15Hospital de Amor Nossa Senhora (HANS), Fundação PIO XII, Barretos, Brazil
Ph.D.Cor Fontes
16Hospital Universitário Júlio Muller, Cuiabá, Brazil
Ph.D.Ana Lyrio
17Universidade Federal de Mato Grosso do Sul (FAMED), Hospital Universitário Maria Aparecida Pedrossian, Campo Grande, Brazil
Ph.D.Mauricio Nogueira
18Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, Brazil
Ph.D.Fernanda Boulos
1Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil
M.ScEsper Kallas
1Clinical Trials and Pharmacovigilance Center, Instituto Butantan, São Paulo, Brazil
Ph.D.Article usage
Posted April 23, 2024.
Efficacy and Safety of an Inactivated Whole-Virion SARS-CoV-2 Vaccine (CoronaVac) in Brazilian Healthcare Professionals: The PROFISCOV Trial
José Moreira, Elizabeth G. Patiño, Patricia Emilia Braga, Pedro Pacheco, Caroline Curimbaba, Christopher Gast, Ricardo Palácios, Mauro Teixeira, Fabiano Ramos, Gustavo Romero, Fabio Leal, Luiz Junior, Luiz Camargo, Francisco Aoki, Eduardo Coelho, André Siqueira, Sonia Raboni, Danise Oliveira, Paulo Tarso, Cor Fontes, Ana Lyrio, Mauricio Nogueira, Fernanda Boulos, Esper Kallas
medRxiv 2024.04.22.24306197; doi: https://doi.org/10.1101/2024.04.22.24306197
Efficacy and Safety of an Inactivated Whole-Virion SARS-CoV-2 Vaccine (CoronaVac) in Brazilian Healthcare Professionals: The PROFISCOV Trial
José Moreira, Elizabeth G. Patiño, Patricia Emilia Braga, Pedro Pacheco, Caroline Curimbaba, Christopher Gast, Ricardo Palácios, Mauro Teixeira, Fabiano Ramos, Gustavo Romero, Fabio Leal, Luiz Junior, Luiz Camargo, Francisco Aoki, Eduardo Coelho, André Siqueira, Sonia Raboni, Danise Oliveira, Paulo Tarso, Cor Fontes, Ana Lyrio, Mauricio Nogueira, Fernanda Boulos, Esper Kallas
medRxiv 2024.04.22.24306197; doi: https://doi.org/10.1101/2024.04.22.24306197
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (628)
- Anesthesia (165)
- Cardiovascular Medicine (2377)
- Dermatology (207)
- Emergency Medicine (379)
- Epidemiology (11775)
- Forensic Medicine (10)
- Gastroenterology (703)
- Genetic and Genomic Medicine (3744)
- Geriatric Medicine (350)
- Health Economics (634)
- Health Informatics (2399)
- Health Policy (933)
- Hematology (341)
- HIV/AIDS (782)
- Medical Education (365)
- Medical Ethics (105)
- Nephrology (398)
- Neurology (3507)
- Nursing (198)
- Nutrition (526)
- Oncology (1824)
- Ophthalmology (538)
- Orthopedics (219)
- Otolaryngology (287)
- Pain Medicine (233)
- Palliative Medicine (66)
- Pathology (446)
- Pediatrics (1035)
- Primary Care Research (420)
- Public and Global Health (6145)
- Radiology and Imaging (1280)
- Respiratory Medicine (828)
- Rheumatology (379)
- Sports Medicine (323)
- Surgery (402)
- Toxicology (50)
- Transplantation (172)
- Urology (146)